Document is current
Any future updates will be listed below
-
Authors
Lim, Sean H.
Linton, Kim M.
Collins, Graham P.
Dhondt, Joke http://orcid.org/0000-0003-2900-3806
Caddy, Joshua
Rossiter, Liz
Vadher, Karan
Fines, Keira
Rogers, Laura E.
Fernando, Diana
Stanton, Louise
Davies, Andrew J.
Johnson, Peter W. M.
Griffiths, Gareth
-
Funding
Funding for this research was provided by:
Cancer Research UK (CRUKD/17/008)
- License Information
-
More Information
Article History
Received: 27 July 2018
Accepted: 16 October 2018
First Online: 9 November 2018
Ethics approval and consent to participate
: The trial received a favourable ethical opinion from South Central – Oxford A Ethics Committee (17/SC/0317) and has Health Research Authority approval (IRAS 223132). All participants will provide written informed consent before participating and are free to withdraw at any time.
: Not applicable.
: SHL is co-inventor on a patent application filed (JDM84560P.GBA) and receives research funding from Celldex Therapeutics.AJD declares the following competing interests:UnorderedList removedAll other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
